Exelixis (EXEL) News Today $37.39 -0.32 (-0.85%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$37.22 -0.16 (-0.44%) As of 08/7/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EXEL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Mutual of America Capital Management LLC1 hour ago | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. ...August 6 at 7:04 PM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 6 at 6:40 PM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. ...August 6 at 11:05 AM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 6 at 10:30 AM | prnewswire.comBlair William & Co. IL Has $10.81 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)August 6 at 5:07 AM | marketbeat.comAvantax Advisory Services Inc. Makes New $551,000 Investment in Exelixis, Inc. (NASDAQ:EXEL)August 6 at 3:24 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Ruffer LLPAugust 5 at 6:07 AM | marketbeat.comCommerce Bank Sells 12,347 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 4, 2025 | marketbeat.comJupiter Asset Management Ltd. Boosts Stake in Exelixis, Inc. (NASDAQ:EXEL)August 3, 2025 | marketbeat.comKazazian Asset Management LLC Sells 22,350 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 3, 2025 | marketbeat.comLSV Asset Management Lowers Stake in Exelixis, Inc. (NASDAQ:EXEL)August 3, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Lowered to Buy Rating by Wall Street ZenAugust 3, 2025 | marketbeat.comResearch Analysts Set Expectations for Exelixis Q3 EarningsAugust 3, 2025 | americanbankingnews.comWilliam Blair Has Optimistic Outlook of Exelixis Q3 EarningsAugust 2, 2025 | marketbeat.comXTX Topco Ltd Increases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)August 2, 2025 | marketbeat.comFederated Hermes Inc. Grows Stock Position in Exelixis, Inc. (NASDAQ:EXEL)August 2, 2025 | marketbeat.comMackenzie Financial Corp Sells 61,906 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 2, 2025 | marketbeat.comVestcor Inc Buys 92,211 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 1, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Position Increased by Harvest Fund Management Co. LtdAugust 1, 2025 | marketbeat.comPicton Mahoney Asset Management Has $599,000 Position in Exelixis, Inc. (NASDAQ:EXEL)August 1, 2025 | marketbeat.comExelixis Earnings Call: Growth Amid ChallengesAugust 1, 2025 | theglobeandmail.comExelixis' (EXEL) "Market Outperform" Rating Reaffirmed at JMP SecuritiesAugust 1, 2025 | americanbankingnews.comRoyal Bank Of Canada Cuts Exelixis (NASDAQ:EXEL) Price Target to $45.00August 1, 2025 | americanbankingnews.comMorgan Stanley Cuts Exelixis (NASDAQ:EXEL) Price Target to $46.00August 1, 2025 | americanbankingnews.comExelixis (NASDAQ:EXEL) Given a $38.00 Price Target by UBS Group AnalystsAugust 1, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELJuly 31, 2025 | prnewswire.comExelixis: Zanzalintinib Sees Mixed Progress, Cabozantinib Grinds UpwardsJuly 31, 2025 | seekingalpha.comUBS Group Issues Pessimistic Forecast for Exelixis (NASDAQ:EXEL) Stock PriceJuly 31, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Seizert Capital Partners LLCJuly 31, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Earns "Outperform" Rating from William BlairJuly 31, 2025 | americanbankingnews.comTruist Financial Issues Pessimistic Forecast for Exelixis (NASDAQ:EXEL) Stock PriceJuly 31, 2025 | americanbankingnews.comAssessing Exelixis: Insights From 20 Financial AnalystsJuly 31, 2025 | benzinga.comExelixis (EXEL) Tumbles 16.8% as Q2 Earnings DisappointJuly 31, 2025 | msn.comExelixis (NASDAQ:EXEL) Shares Gap Down After Analyst DowngradeJuly 31, 2025 | americanbankingnews.comExelixis (NASDAQ:EXEL) Price Target Lowered to $49.00 at Truist FinancialJuly 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Shares Gap Down Following Analyst DowngradeJuly 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Earns Outperform Rating from William BlairJuly 30, 2025 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for Exelixis (NASDAQ:EXEL) Stock PriceJuly 30, 2025 | marketbeat.comMorgan Stanley Issues Pessimistic Forecast for Exelixis (NASDAQ:EXEL) Stock PriceJuly 30, 2025 | marketbeat.comExelixis Sees Unusually High Options Volume (NASDAQ:EXEL)July 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Receives "Market Outperform" Rating from JMP SecuritiesJuly 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Earns "Buy" Rating from GuggenheimJuly 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Price Target Raised to $41.00July 30, 2025 | marketbeat.comBayforest Capital Ltd Takes Position in Exelixis, Inc. (NASDAQ:EXEL)July 30, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSJuly 29, 2025 | marketbeat.comAnalyst Surprised By Exelixis Q2 Revenue Miss, Delays STELLAR-304 Readout, Halts STELLAR-305 Phase 3 PlansJuly 29, 2025 | benzinga.comAnalyst Surprised By Exelixis Q2 Revenue Miss, Delays STELLAR-304 Readout, Halts STELLAR-305 Phase 3 PlansJuly 29, 2025 | benzinga.comExelixis shares tumble as revenue missJuly 29, 2025 | in.investing.comExelixis shares tumble over 12% after revenue miss and zanzalintinib trial haltJuly 29, 2025 | msn.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼0.820.39▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2817▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News BioMarin Pharmaceutical News Exact Sciences News Halozyme Therapeutics News Repligen News Ionis Pharmaceuticals News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
